• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Bioxodes

    News headline image
    Bioxodes presents BIOX-101 clinical data showing breakthrough potential for stroke in webcast with Prof Dr Robin Lemmens
    From Bioxodes
    Via GlobeNewswire
    News headline image
    Bioxodes appoints industry veteran Philippe Monteyne as chairman as it accelerates late-stage development of breakthrough stroke candidate
    From Bioxodes
    Via GlobeNewswire
    News headline image
    Bioxodes positive Phase 2a stroke data show breakthrough potential of innovative therapeutic candidate BIOX-101
    From Bioxodes
    Via GlobeNewswire
    News headline image
    Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients
    From Bioxodes
    Via GlobeNewswire
    News headline image
    Bioxodes obtains Orphan Drug Designation for hemorrhagic stroke therapeutic candidate in US and Europe
    From Bioxodes
    Via GlobeNewswire
    News headline image
    Bioxodes secures new funds to reach early 2025 milestones and pursue Series B financing
    From Bioxodes
    Via GlobeNewswire
    News headline image
    Bioxodes meets enrollment milestone in Phase 2a intracerebral hemorrhagic stroke trial
    From Bioxodes
    Via GlobeNewswire
    News headline image
    Bioxodes reports positive DMC meeting for BIOX-101 Phase 2a trial in intracerebral hemorrhagic stroke
    From Bioxodes
    Via GlobeNewswire
    News headline image
    Bioxodes meets first Phase 2a patient enrollment milestone with BIOX-101 in intracerebral hemorrhagic stroke
    From Bioxodes
    Via GlobeNewswire
    News headline image
    Bioxodes receives European Patent Office intention to grant patent, offering lead asset broad protection in thromboinflammation
    From Bioxodes
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.